Home
We're committed to partnering with those living with lupus, their loved ones, friends, and the medical community to fulfill our vision of a life free of lupus.
We can't wait to see you this fall! Get registered for a 2024 Walk to End Lupus Now event today!
Join us on Saturday, May 18th, in-person for the 2024 Lupus & You: Richmond Empowerment Conference
Connect with the community, hear from local experts, and discover the exciting future of lupus care. Don't miss this empowering event in your own community.
Location: The Valentine Museum, 1015 E Clay St, Richmond, VA 23219
Time: 8:30 am - 12 pm
Join us on Saturday, June 15th, in-person for the 2024 Lupus & You: Baltimore Empowerment Conference
Connect with the community, hear from local experts, and discover the exciting future of lupus care. Don't miss this empowering event in your own community.
Location: University of Maryland, Baltimore - Leadership Hall, 685 W. Baltimore Street (entry from HSF I)
Baltimore, MD 21201
Time: 8:30 am - 12 pm
This event will be in November! More information coming soon!
Follow the DMV Region on Instagram and join a local Facebook Group! Meet and connect with other lupus warriors, share your story, and stay up to date on what is happening in the community and at the LFA!
We are so excited to have launched the DMV Instagram page this year! Follow us today at @lfa_dmv
Join a local Facebook group! You can find a group for Washington DC, Baltimore, and Richmond!
Hello! My name is Leanna Bennett, and I am the National Walk Manager supporting the DMV! Are you interested in getting involved in the lupus community by joining us at the walk, getting involved in a committee, corporate sponsorship, or simply to volunteer?
Reach out to me to learn more about ways to get involved or to see what events and programming are coming up for the DMV region.
Vitamin D affects how your immune system works, and plays a role in controlling certain types of inflammation, including the type that leads to autoimmune...
Ventus Therapeutics announced the successful completion of the phase 1 clinical trial for VENT-03 with plans to initiate a phase 2 study for people with...
In a strategic move to enhance their immunology portfolio, GSK has announced an agreement to acquire experimental therapy CMG1A46 from Chimagen Biosciences.